Matteo Cecchi, PharmD PhD

Led the strategic development and execution of medical affairs plans across the WEU Southern Cluster, achieving significantly increase in KOL engagement. Directed cross-functional teams to deliver impactful medical education programs, resulting in improvement in healthcare professional knowledge and adoption of key therapies. Developed and implemented medical communication strategies, ensuring consistent and accurate dissemination of scientific information across the region. Managed medical budgets and resources, delivering projects within budget. Cultivated strong relationships with key external stakeholders, including KOLs, patient advocacy groups, and regulatory authorities, enhancing the company's medical reputation and influence. Provided strategic medical insights to support product launches and lifecycle management, contributing to market share increase.

Act as Medical Affairs representative for Acute Therapies (Italy & Greece). Establish and maintain KOL relationships (peer-to-peer). Deliver scientific support at medical congresses. Manage Investigator Initiated Studies (IIS) as primary liaison. Maintain up-to-date medical education (internal & external).

Conducted rigorous systematic reviews and meta-analyses, contributing to evidence-based healthcare guidelines used by over 10,000 clinicians globally. Developed and refined search strategies for complex medical literature, increasing the efficiency of data retrieval by 25%. Collaborated with international teams of researchers and clinicians, facilitating the synthesis of high-quality evidence for clinical decision-making. Evaluated the methodological quality of clinical trials, ensuring the reliability and validity of synthesized research findings. Authored and co-authored peer-reviewed publications and reports, disseminating key research findings to the medical community and influencing clinical practice.

Developed and implemented national medical strategies, resulting in a 15% increase in key opinion leader (KOL) engagement within six months. Led the creation and dissemination of evidence-based medical information, ensuring 100% compliance with regulatory guidelines. Collaborated with sales and marketing teams to deliver impactful medical training, contributing to a 20% growth in product adoption. Conducted thorough analyses of clinical data to provide strategic insights, influencing the development of three new medical education programs.

Developed comprehensive medical communication materials, including manuscripts, abstracts, and presentations, resulting in a 95% client satisfaction rate. Crafted engaging and scientifically accurate content for diverse audiences, contributing to a 30% increase in client website traffic. Conducted in-depth literature reviews and data analyses to deliver evidence-based medical content within strict deadlines, consistently meeting project milestones. Translated complex scientific information into clear, concise, and accessible language for healthcare professionals and patients, enhancing medical literacy and understanding.

Established and implemented robust safety surveillance protocols, resulting in a 25% reduction in reporting errors. Conducted thorough analyses of adverse event data, identifying and mitigating potential safety risks, preventing 3 critical safety issues. Managed and maintained comprehensive safety databases, ensuring 100% data integrity and compliance with regulatory requirements. Prepared and submitted detailed safety reports to regulatory authorities, consistently meeting all deadlines and achieving a 98% first-time approval rate.

Directed the execution of multiple Phase II-III clinical trials, achieving a 90% on-time study completion rate. Led cross-functional project teams, streamlining study processes and reducing study timelines by 15%. Developed and implemented risk mitigation strategies, ensuring 100% compliance with GCP and regulatory guidelines. Managed study budgets and resources, delivering projects within budget and achieving a 10% cost savings. Negotiated contracts with vendors and clinical sites, resulting in favorable terms and improved study efficiency.

Oversaw end-to-end supply chain activities for Boehringer Ingelheim's respiratory product line, with a focus on Spiriva. Responsibilities included inventory management and logistics coordination

Faculty of Pharmacy, University of Lisbon (FFUL), Lisbon, portugal. Formulation and characterization of PLGA/PVA nanoparticles. Supervisor: A.J.Almeida

lmplementation of educational activities aimed at improving the appropriateness of the prescription of CRRT and EBPT in selected ICUs from the Italian ARRT Registry

- PHARMACEUTICAL MARKETING - SALES MANAGEMENT - MARKET RESEARCH AND FORECASTING - MEDICAL MANAGEMENT - MARKET ACCESS - REGULATORY AFFAIRS - FINANCE AND BUDGET MANAGEMENT

• Drug Development • Clinical Trial (observational and interventional studies) • ICH, GCP, GMP, D.M. 21/12/07 N. 51, D.M. 24/06/03 N.211, D.M. 06/11/07 N. 200, D.M. 17/12/04 (No profit trial), Annex 13 • QA and QC in clinical trials • Drug safety • Monitoring (D.M. 15/07/11, Feasibility and PSV, SIV, SMV, Close-out, Drug accountability, Essential documents, Source documents and SDV)

Nov.2007-Jan.2008 Registration at Italian Pharmaceutical Society